[Male breast cancer]

Nihon Rinsho. 2000 Apr:58 Suppl:571-4.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use
  • BRCA1 Protein / genetics
  • BRCA2 Protein
  • Breast Neoplasms, Male* / etiology
  • Breast Neoplasms, Male* / therapy
  • Chemotherapy, Adjuvant
  • Estrogen Antagonists / therapeutic use
  • Estrogens / adverse effects
  • Feminization / complications
  • Germ-Line Mutation
  • Humans
  • Klinefelter Syndrome / complications
  • Male
  • Mastectomy, Segmental
  • Neoplasm Proteins / genetics
  • Prognosis
  • Risk Factors
  • Tamoxifen / therapeutic use
  • Transcription Factors / genetics

Substances

  • Antineoplastic Agents, Hormonal
  • BRCA1 Protein
  • BRCA2 Protein
  • Estrogen Antagonists
  • Estrogens
  • Neoplasm Proteins
  • Transcription Factors
  • Tamoxifen